Literature DB >> 8012074

Malignant pheochromocytoma with hepatic metastasis diagnosed 20 years after resection of the primary adrenal lesion.

S Tanaka1, T Ito, J Tomoda, T Higashi, G Yamada, T Tsuji.   

Abstract

A 59-year-old woman developed multiple hepatic tumors 20 years after resection of pheochromocytoma of the left adrenal gland. Thin-needle aspiration biopsy of the tumor at segment 2 of the liver under ultrasound control showed histology compatible to pheochromocytoma. Then, on the basis of the diagnosis of hepatic metastasis of malignant pheochromocytoma, transcatheter arterial embolization (TAE) was performed for the purpose of the treatment of hepatic metastasis. After TAE, the size of the hepatic metastatic lesions was decreased. The present case suggests the necessity of long-term follow-up in pheochromocytoma cases.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8012074     DOI: 10.2169/internalmedicine.32.789

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  11 in total

Review 1.  Malignant pheochromocytomas and paragangliomas: a diagnostic challenge.

Authors:  Oliver Gimm; Catherine DeMicco; Aurel Perren; Francesco Giammarile; Martin K Walz; Laurent Brunaud
Journal:  Langenbecks Arch Surg       Date:  2011-11-29       Impact factor: 3.445

Review 2.  Outcomes of patients with metastatic phaeochromocytoma and paraganglioma: A systematic review and meta-analysis.

Authors:  Oksana Hamidi; William F Young; Lucinda Gruber; John Smestad; Qi Yan; Oscar J Ponce; Larry Prokop; Mohammad Hassan Murad; Irina Bancos
Journal:  Clin Endocrinol (Oxf)       Date:  2017-08-17       Impact factor: 3.478

3.  Gene expression profiling of benign and malignant pheochromocytoma.

Authors:  Frederieke M Brouwers; Abdel G Elkahloun; Peter J Munson; Graeme Eisenhofer; Jennifer Barb; W Marston Linehan; Jacques W M Lenders; Ronald De Krijger; Massimo Mannelli; Robert Udelsman; Idris T Ocal; Barry L Shulkin; Stefan R Bornstein; Jan Breza; Lucia Ksinantova; Karel Pacak
Journal:  Ann N Y Acad Sci       Date:  2006-08       Impact factor: 5.691

4.  Patient with inoperable pheochromocytoma.

Authors:  D Brancíková; Z Mechl; Z Adam; E Jandáková; Z Pavlovský; V Válek; Z Andrašina
Journal:  Curr Oncol       Date:  2015-06       Impact factor: 3.677

5.  Successful outcome after resection of liver metastasis arising from an extraadrenal retroperitoneal paraganglioma that appeared 9 years after surgical excision of the primary lesion.

Authors:  Takehiro Noda; Hiroaki Nagano; Atsushi Miyamoto; Hiroshi Wada; Masahiro Murakami; Shogo Kobayashi; Shigeru Marubashi; Yutaka Takeda; Keizo Dono; Koji Umeshita; Kenichi Wakasa; Morito Monden
Journal:  Int J Clin Oncol       Date:  2009-10-25       Impact factor: 3.402

Review 6.  Treatment of malignant pheochromocytoma.

Authors:  R Adjallé; P F Plouin; K Pacak; H Lehnert
Journal:  Horm Metab Res       Date:  2009-08-11       Impact factor: 2.936

Review 7.  Laparoscopic surgery for malignant adrenal tumors.

Authors:  G N Zografos; G Vasiliadis; A N Farfaras; C Aggeli; M Digalakis
Journal:  JSLS       Date:  2009 Apr-Jun       Impact factor: 2.172

8.  Disentangling of Malignancy from Benign Pheochromocytomas/Paragangliomas.

Authors:  Kyong Young Kim; Jung Hee Kim; A Ram Hong; Moon-Woo Seong; Kyu Eun Lee; Su-Jin Kim; Sang Wan Kim; Chan Soo Shin; Seong Yeon Kim
Journal:  PLoS One       Date:  2016-12-16       Impact factor: 3.240

9.  Preoperative embolization reduces the risk of cathecolamines release at the time of surgical excision of large pelvic extra-adrenal sympathetic paraganglioma.

Authors:  Nicola Di Daniele; Maria Paola Canale; Manfredi Tesauro; Valentina Rovella; Roberto Gandini; Orazio Schillaci; Federica Cadeddu; Giovanni Milito
Journal:  Case Rep Endocrinol       Date:  2012-09-04

10.  Paraganglioma of the pancreas: a potentially functional and malignant tumor.

Authors:  Liyang Zhang; Quan Liao; Ya Hu; Yupei Zhao
Journal:  World J Surg Oncol       Date:  2014-07-17       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.